The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of european ancestry with a heterozygous brca1 or brca2 pathogenic variant

HIGHLIGHTS

• who: Inge M.M. Lakeman from the (UNIVERSITY) have published the paper: The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant, in the Journal: (JOURNAL) of 10/06/2021
• what: The authors investigated whether the 313 variant-based PRS for breast cancer is associated with contralateral breast cancer risk among women of European ancestry with pathogenic variants in BRCA1/2 and explored the implications for contralateral breast cancer risk prediction for these women.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.